BioCentury
ARTICLE | Clinical News

TheraTech Inc, Procter and Gamble Co. regulatory update

January 2, 1996 8:00 AM UTC

THRT filed an NDA with the FDA for its estradiol transdermal patch as a hormone replacement therapy. The patch uses THRT's matrix transdermal technology to deliver the hormone continuously for up to f...